These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32097995)

  • 21. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1127-1150. PubMed ID: 31586514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. INTRAVENOUS CONTRAST IN PATIENTS WITH DIABETES ON METFORMIN: NEW COMMON SENSE GUIDELINES.
    Shah AD; McHargue C; Yee J; Rushakoff RJ
    Endocr Pract; 2016 Apr; 22(4):502-5. PubMed ID: 26789340
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal function markers and metformin eligibility.
    Tavares Bello C; Castro Fonseca R; Sousa Santos F; Sequeira Duarte J; Azinheira J; Vasconcelos C
    Minerva Endocrinol; 2018 Sep; 43(3):246-252. PubMed ID: 28565889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic kidney diseases, metformin and lactic acidosis].
    Borbély Z
    Vnitr Lek; 2016 Apr; 62(4):299-303. PubMed ID: 27250607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of serum creatinine and kidney function among incident metformin users.
    Schorr M; Hemmelgarn BR; Tonelli M; Soo A; Manns BJ; Bresee LC;
    Can J Diabetes; 2013 Aug; 37(4):226-230. PubMed ID: 24070885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.
    Sipahi S; Solak Y; Acikgoz SB; Genc AB; Yildirim M; Yilmaz U; Nalbant A; Tamer A
    Int Urol Nephrol; 2016 Aug; 48(8):1305-1312. PubMed ID: 27102431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of metformin with intravenous iodinated contrast media and precautions.
    Shah MA; Niazi SG; Tahir IM; Shahid I; Parveen A; Sana S; Akhter N; Iftikhar N; Ashraf S; Siddique Z; Mushtaq Y; Khan M; Akram M
    Pak J Pharm Sci; 2019 Mar; 32(2 (Supplementary)):859-863. PubMed ID: 31103983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystatin C measurement leads to lower metformin dosage in elderly type 2 diabetic patients.
    Šálek T; Adamíková A
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):298-302. PubMed ID: 30218617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? Yes, They Should Be Relaxed! What's the Fuss?
    Bakris GL; Molitch ME
    Diabetes Care; 2016 Jul; 39(7):1287-91. PubMed ID: 27330130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease.
    Scheen AJ
    Expert Opin Drug Metab Toxicol; 2013 May; 9(5):529-50. PubMed ID: 23461781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 2 diabetes treatment and progression of chronic kidney disease in Italian family practice.
    Ermini G; Tosetti C; Zocchi D; Mandreoli M; Caletti MT; Marchesini G;
    J Endocrinol Invest; 2019 Jul; 42(7):787-796. PubMed ID: 30465248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetes.
    Scheen AJ
    Diabetes Metab; 2019 Apr; 45(2):110-121. PubMed ID: 30477733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of prescribing metformin according to eGFR instead of serum creatinine level: A study based on Korean National Health and Nutrition Examination Survey (KNHANES) 2009-2014.
    Moon SJ; Ahn CH; Cho YM
    PLoS One; 2017; 12(4):e0175334. PubMed ID: 28399132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.
    Hung SC; Chang YK; Liu JS; Kuo KL; Chen YH; Hsu CC; Tarng DC
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):605-14. PubMed ID: 26094107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of continuation of metformin prior to elective coronary angiography on acute contrast nephropathy in patients with normal or mildly impaired renal functions.
    Oktay V; Calpar Çıralı İ; Sinan ÜY; Yıldız A; Ersanlı MK
    Anatol J Cardiol; 2017 Nov; 18(5):334-339. PubMed ID: 29111980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material: Conundrum Continued.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
    Invest Radiol; 2018 Oct; 53(10):616-622. PubMed ID: 29762257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy: Risk of metformin use in patients with T2DM and advanced CKD.
    Schernthaner G; Schernthaner-Reiter MH
    Nat Rev Endocrinol; 2015 Dec; 11(12):697-9. PubMed ID: 26284445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin in patients with chronic kidney disease: strengths and weaknesses.
    Rocha A; Almeida M; Santos J; Carvalho A
    J Nephrol; 2013; 26(1):55-60. PubMed ID: 22641582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin monitoring and change in serum creatinine levels in patients undergoing radiologic procedures involving administration of intravenous contrast media.
    Parra D; Legreid AM; Beckey NP; Reyes S
    Pharmacotherapy; 2004 Aug; 24(8):987-93. PubMed ID: 15338847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice.
    Abe M; Okada K; Soma M
    Curr Drug Metab; 2011 Jan; 12(1):57-69. PubMed ID: 21303332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.